• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

How the Apple Watch & other wearables could help highlight early signs of diabetes

February 7, 2018 By Sarah Faulkner

diabetesResearchers have found that using Cardiogram‘s deep neural network technology, data collected from ordinary wearables could help flag early signs of diabetes.

In one 14,000-person study, the company’s DeepHeart technology was able to distinguish between people with and without diabetes at 85% accuracy.

Investigators from Cardiogram and the University of California San Francisco presented the study’s findings today at the AAAI Conference on Artificial Intelligence in New Orleans.

In the U.S., more than 100 million adults are living with prediabetes or diabetes, according to Cardiogram co-founder Brandon Ballinger, and one in every four people with diabetes is undiagnosed. Ballinger touted the large-scale study as the first to demonstrate that ordinary heart-rate sensors could be used to ID early warning signs of diabetes when paired up with an artificial intelligence-based algorithm.

To train the DeepHeart network to detect diabetes, researchers recruited 14,001 Cardiogram users and collected health sensor data from people with and without diabetes, hypertension, sleep apnea, atrial fibrillation and high cholesterol.

“Your heart is connected with your pancreas via the autonomic nervous system,” co-founder Johnson Hsieh explained in prepared remarks.

“As people develop the early stages of diabetes, their pattern of heart rate variability shifts. In 2015, the Framingham Heart Study showed that high resting heart rate and low heart rate variability predicts who will develop diabetes over a 12-year period. In 2005, the ARIC study showed that heart rate variability declines faster in diabetics than non-diabetics over a 9-year period.”

Cardiogram’s app is compatible with all versions of the Apple Watch and any Android Wear watch with a heart rate sensor, according to the company. This year, Cardiogram plans to integrate its DeepHeart network directly into its app.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Big Data, Clinical Trials, Diabetes, Diagnostics, Featured, mHealth (Mobile Health) Tagged With: Apple, cardiogram, fitbit

IN CASE YOU MISSED IT

  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Go-Pen ApS wins FDA nod for user-filled insulin pen

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS